Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
0.4801
-0.0111 (-2.26%)
Apr 1, 2025, 10:35 AM EDT - Market open
Ainos Employees
Ainos had 44 employees as of December 31, 2024. The number of employees decreased by 2 or -4.35% compared to the previous year.
Employees
44
Change (1Y)
-2
Growth (1Y)
-4.35%
Revenue / Employee
$471
Profits / Employee
-$337,799
Market Cap
7.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AIMD News
- 7 days ago - Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025 - Accesswire
- 19 days ago - Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose's Potential in Chip Manufacturing and More - Accesswire
- 21 days ago - Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing - Accesswire
- 24 days ago - Ainos Reports Full Year 2024 Financial Results - Accesswire
- 24 days ago - Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here - Accesswire
- 26 days ago - Ainos and ugo to Develop the World's First Robot With a Sense of Smell - Accesswire
- 2 months ago - Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation - Accesswire
- 2 months ago - Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025 - Accesswire